Tulobuterol is a potential therapeutic drug in congenital myasthenic syndrome.

Pediatr Int

Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.

Published: January 2022

Download full-text PDF

Source
http://dx.doi.org/10.1111/ped.15115DOI Listing

Publication Analysis

Top Keywords

tulobuterol potential
4
potential therapeutic
4
therapeutic drug
4
drug congenital
4
congenital myasthenic
4
myasthenic syndrome
4
tulobuterol
1
therapeutic
1
drug
1
congenital
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!